Themis Medicare - Quaterly Results

21 May 2022 Evaluate
The sales moved up 29.18% to Rs. 797.97 millions for the March 2022 quarter as compared to Rs. 617.73 millions during the year-ago period.A humble growth in net profit of 10.78% reported in the quarter ended March 2022 to Rs. 75.51  millions from Rs. 68.16 millions.Operating profit surged to 162.62 millions from the corresponding previous quarter of 134.89 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202203 202103 % Var 202203 202103 % Var 202203 202103 % Var
Sales 797.97 617.73 29.18 3946.14 2306.70 71.07 3946.14 2306.70 71.07
Other Income 18.38 8.82 108.39 65.41 36.22 80.59 65.41 36.22 80.59
PBIDT 162.62 134.89 20.56 1021.92 535.06 90.99 1021.92 535.06 90.99
Interest 19.28 30.87 -37.54 87.74 127.12 -30.98 87.74 127.12 -30.98
PBDT 143.34 104.02 37.80 934.18 407.94 129.00 934.18 407.94 129.00
Depreciation 23.89 23.81 0.34 94.80 85.46 10.93 94.80 85.46 10.93
PBT 119.45 80.21 48.92 839.38 322.48 160.29 839.38 322.48 160.29
TAX 43.94 12.05 264.65 223.81 56.28 297.67 223.81 56.28 297.67
Deferred Tax 13.94 12.05 15.68 56.31 56.28 0.05 56.31 56.28 0.05
PAT 75.51 68.16 10.78 615.57 266.20 131.24 615.57 266.20 131.24
Equity 92.00 91.88 0.13 92.00 91.88 0.13 92.00 91.88 0.13
PBIDTM(%) 20.38 21.84 -6.67 25.90 23.20 11.64 25.90 23.20 11.64

Themis Medicare Share Price

263.10 0.75 (0.29%)
01-Nov-2024 18:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1858.70
Dr. Reddys Lab 1258.55
Cipla 1559.20
Lupin 2198.25
Zydus Lifesciences 1004.00
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.